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Background: Neurocognitive decline observed after radiotherapy (RT) for brain tumors in long time survivors is
attributed to radiation exposure of the hippocampus and the subventricular zone (SVZ). The potential of sparing
capabilities for both structures by optimized intensity modulated stereotactic radiotherapy (IMSRT) is investigated.
Methods: Brain tumors were irradiated by stereotactic 3D conformal RT or IMSRT using m3 collimator optimized for
PTV and for sparing of the conventional OARs (lens, retina, optic nerve, chiasm, cochlea, brain stem and the medulla
oblongata). Retrospectively both hippocampi and SVZ were added to the list of OAR and their dose volume histograms
were compared to those from two newly generated IMSRT plans using 7 or 14 beamlets (IMSRT-7, IMSRT-14) dedicated
for optimized additional sparing of these structures. Conventional OAR constraints were kept constant. Impact of plan
complexity and planning target volume (PTV) topography on sparing of both hippocampi and SVZ, conformity index
(CI), the homogeneity index (HI) and quality of coverage (QoC) were analyzed. Limits of agreement were used to
compare sparing of stem cell niches with either IMSRT-7 or IMSRT-14. The influence of treatment technique related to
the topography ratio between PTV and OARs, realized in group A-D, was assessed by a mixed model.
Results: In 47 patients CI (p≤ 0.003) and HI (p < 0.001) improved by IMSRT-7, IMSRT-14, QoC remained stable (p≥ 0.50)
indicating no compromise in radiotherapy. 90% of normal brain was exposed to a significantly higher dose using
IMSRT. IMSRT-7 plans resulted in significantly lower biologically effective doses at all four neural stem cell structures,
while contralateral neural stem cells are better spared compared to ipsilateral. A further increase of the number of
beamlets (IMSRT-14) did not improve sparing significantly, so IMSRT-7 and IMSRT-14 can be used interchangeable.
Patients with tumors contacting neither the subventricular zone nor the cortex benefit most from IMSRT (p < 0.001).
Conclusion: The feasibility of neural stem cell niches sparing with sophisticated linac based inverse IMSRT with 7
beamlets in an unselected cohort of intracranial tumors in relation to topographic situation has been demonstrated.
Clinical relevance testing neurotoxicity remains to be demonstrated.
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Table 1 Demographic and tumor characteristics and
radiotherapy planning details
n (male: female) 47 (26:21)











3 D conformal plan a 27
micromultileaf collimator (m3) IMSRT a 20
total radiation dose (ICRU 50)
mean ± SD (range) 55.19 ±3.77 (50–60) Gy
PTV volume
mean ± SD (range) 79.13 ±66.62 (2.1-255.3) ml





a: to fulfil of conventionally defined organs at risk constraints (see text).
b: according to the definition of [10].
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Research in the field of neural stem cells has made a
quantum leap and yielded complete new insights upon
the regeneration of brain cells and functions during the
last 15 years. The hippocampal precursor cells, that
generate new neurons with their particular function,
represent a ‘neurogenic reserve’ – the potential to re-
main flexible and plastic in hippocampal learning [1].
Neural stem cells reside in the subventricular zone
(SVZ) of the adult mammalian brain. It is concluded
that SVZ astrocyte like cells act as neural stem cells in
both the normal and regenerating brain [2-4]. The
dentate granule cell layer of the hippocampal formation
has the distinctive property of ongoing neurogenesis,
that continues throughout adult life. Although the func-
tion of these newly generated neurons and the mecha-
nisms that control their birth are not yet fully understood.
Age, activity and psychosocial stress have all been demon-
strated to regulate this type of neurogenesis. Radiation- and
chemotherapy-induced damage to progenitor populations,
responsible for maintenance of white matter integrity and
adult hippocampal neurogenesis, is now believed to play a
major role in the neurocognitive impairment many cancer
survivors experience [5,6]. Therefore functional recovery paved
to a major part by cellular restoring may be compromised by
radiation therapy.
We explored the potential of modern intensity mod-
ulated stereotactic radiotherapy (IMSRT) for sparing
the hippocampus, harboring the dentate gyrus and the
subventricular zones (SVZ) adjacent to the lateral
ventricles.
Material and methods
All consecutively treated patients, who received high dose
fractionated stereotactic radiotherapy for intracranial tu-
mors between 3/2007 and 5/2010, were retrieved from the
institutional data base for analysis in this retrospective plan-
ning study. Patients with a maximum diameter of the plan-
ning target volume (PTV) of 100 mm and above were
excluded. In all patients the tumor to be treated has been
confirmed by histology after biopsy, partial or gross tumor
resection. The histologic type of tumor is given in Table 1.
Anaplastic glioma, glioblastoma (GBM) and gliosarcoma
have been conventionally fractionated with 60 Gy /2 Gy
(total dose/dose per fraction), low grade glioma with 54
Gy /2 Gy, all other entities with 50.4 to 54 Gy /1.8 Gy
(ICRU 50). Patients with unconventional fractionation
schedules were excluded. Patients with GBM and anaplastic
glioma WHO °3 or °4 were given temozolomide, 75 mg/
sqm body surface area, orally every treatment day. The tech-
nique applied was selected in order to match the conven-
tional dose constraints as good as possible. Clinically applied
treatment plans were generated by the following procedures
and planning constraints.Conventional planning procedure
For planning purposes all patients had a plain axial com-
puted tomography (CT) with 2.5 mm slice thickness,
covering the entire brain from the vertex to cervical ver-
tebra 2. The CT data set was taken on a scanner dedicated
for radiotherapy planning. The patient was fixed in the
high precision mask system, encaged in the stereotactic
CT localizer (Brainlab ®, Feldkirchen/Munich, Germany). A
1.5 Tesla magnet resonance image (MRI) rendering vol-
ume scan based on 192 sagittal slices with 0.9 mm thick-
ness was acquired immediately after contrast injection for
all patients to enhance contouring. For delineation, a
gadolinium-enhanced T1-weighted gradient-echo sequence
was used to delineate gross tumor volume (GTV), clinical
target volume (CTV) and planning target volume (PTV).
CT and MRI data sets were fused using the integrated fu-
sion algorithm of the planning software iPlan RT ® version
3.0 and 4.0 (Brainlab, Feldkirchen/Munich, Germany).
GTV was contoured according to the contrast en-
hanced volumes. The CTV was generated by contouring
a margin around the surgical defect (tumor bed) accounting
for microscopic extension in case of incomplete surgical
Figure 1 Right temporal planning target volume (PTV, red) and
organs at risk delineated in the MRI rendering volume data set.
Lenses in pale blue and purple, nn. optici and chiasm in yellow,
brain stem and medulla oblongata in green, the hippocampi and
the subventricular zones (SVZ) in different shades of magenta.
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CTV was chosen 10 mm in high grade tumors (WHO °3
and 4) and 5–7 mm unless the scull would have been ex-
posed in low grade tumors (WHO °2). For meningioma
WHO grade 1 and craniopharyngioma, the selected margin
was 2–3 mm. PTV was generated by an additional margin
of 2 mm in all directions, irrespective of tumor grading to
compensate for daily set-up error.
The following structures (conventional organs at risk,
OARs) were routinely delineated with their maximum dose
accepted in the final plan (constraints given in brackets):
lens (10 Gy), retina (35 Gy), optic nerves (45–50 Gy), chi-
asm (45 Gy), cochlea (45 Gy), brain stem (50 Gy) and me-
dulla oblongata (50 Gy). Contouring was performed in
axial reconstructions of the MRI data set. All plans were
calculated and optimized in Brainlab iPlan RT ® version 3.0
and 4.0 and applied to the patient using the micromultileaf
collimator m3 (Brainlab, Feldkirchen/Munich, Germany).
The preferred treatment plan used forward planned 3D
conformal non-coplanar isocentric fixed beams. If 3D con-
formal RT planning failed to meet any of these constraints,
IMSRT using the step-and-shoot technology was used. An
experienced medical physicist and a radiation oncologist
decided on the applied technology on an individual basis.
All patients were irradiated with plans optimized for sparing
of delineated OARs and yielding acceptable dose homogen-
eity at the PTV. The ICRU 50 criteria with regard to PTV
have been fulfilled in all plans. These plans have been
denominated as “not optimized” to describe the results. The
normal tissue maximum doses have been recorded from
the dose volume histograms (DVH) generated for all three
plans in each patient.
Planning optimized for hippocampal and subventricular
zone (SVZ) sparing
Neural stem cell niches were delineated in all restored
original MRI or CT data sets (Figure 1) for the prospect-
ive optimization process. Left and right hippocampi were
contoured with the assistance of an experienced neuro-
radiologist, according to published guidelines [7]. The
left/right SVZ were contoured around left/right lateral
and third ventricles, creating a 3–5 mm rim immediately
adjacent to their lateral borders [8]. The total volume of
the brain from the vertex down to the foramen magnum
was calculated after the PTV has been excluded, using
Boolean operators. Thus the mean dose applied to 10%
(D 10), 50% (D 50) and 90% (D 90) of the normal brain
volume was generated for all planning procedures in all
patients.
Two intensity modulated plans were generated and opti-
mized for the additionally contoured hippocampi and SVZ.
In order to maintain the constraints of conventionally
contoured OARs, the beam directions had been left un-
changed. The technique of intensity modulated stereotacticradiotherapy was already used in daily routine during
study runtime. Our experiences resulted in a number of
beamlets varying between 10 and 20. 14 beamlets were a
satisfying approach for all cases used in this study. It was a
goal to reduce the number of beamlets (7 beamlets) with
the aim to get robust plans. As a positive side effect, these
kind of plans provide shorter treatment times. In addition
to that a better agreement between measured and calcu-
lated isodoses were expected, by avoiding very small
beamlets. Therefore the first plan was generated using a
leaf sequencer setup of 7 beamlets per beam; the second
plan was generated using 14 beamlets per beam in order
to optimize photon fluence profiles. For describing the re-
sults, these plans have been denominated “IMSRT-7” and
“IMSRT-14” respectively. The constraints for the hippo-
campus and the SVZ were set at 6 Gy maximum total
dose each. The maximum doses for hippocampi and SVZ
obtained in the new plans were transformed into biologic
effective doses (BED) using an alpha-beta ratio of 2 in the
linear quadratic model.
The PTV was subject to an analysis of parameters de-
scribing the quality of dose distribution. The conformity
index (CI) was defined as target volume (TV) divided by
the volume receiving the reference dose (VRI) [9]. The
homogeneity index (HI) was defined as maximum isodose
in the target (Imax) divided by the reference isodose (RI).
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isodose encompassing the target (Imin) divided by refer-
ence isodose (RI).
To explore the impact of topographic tumor site on qual-
ity indices and on potential hippocampus and SVZ sparing
using IMSRT-7 and IMSRT-14 techniques, PTVs were
assessed for their contact with the hippocampus and/or
SVZ and the cortex as described elsewhere [10,11]. Four
groups were segregated: group A (tumors contacting the
SVZ and infiltrating cortex), group B (tumor contacting
SVZ but not involving the cortex), group C (tumor involv-
ing cortex but not contacting the SVZ), group D (tumor in-
volving neither SVZ nor cortex) (Figure 2).
Statistics
The software SPSS (version 18.0; SPSS, Chicago, IL,
USA) was used to describe and analyse non-normal dis-
tributed data. Normal brain exposure and quality indi-
ces of the planning treatment volume, after different
planning modes were tested using the non-parametric
Wilcoxon-(rank sum) – test.
It was hypothesized that the following variables will
impact the dose at the neurogenic stem cell niches: the
structure to be spared (both hippocampi and SVZ), the
topographic site of PTV (group A-D), its laterality
(ipsilataral or contralateral to the PTV) and the mode
of planning (not optimized, IMSRT-7, IMSRT-14). The
agreement of biologic radiation doses for IMSRT-7 and
IMSRT-14 plans at the hippocampi and the SVZ wasFigure 2 Topographic type of 47 intracranial tumors: panels A –D movisualized by Bland-Altman plot [12], which is a method to
analyse the agreement of two different techniques by graph-
ical presentation. For each structure-laterality-combination
(Hippocampus/SVZ-ipsilateral/contralateral) of the two
planning strategies (IMSRT-7; IMSRT-14), the individual
differences of BED between IMSRT-14 and IMSRT-7 are
plotted against their respective averages. The limits of
agreement, which are given by mean value +/− 1.96 times
the standard deviation of the differences, are computed
also. These limits of agreement yield an area including 95%
of the differences. Instead of using the original BED-data
for the Bland-Altman plot the log-transformed BED-data
were used, because a first inspection of the Bland-Altman
plot with the original data showed systematic changes in
the differences.
For this reason the BED data were also estimated in
consideration of structure, group, laterality and treat-
ment plan by applying linear mixed model using SAS
9.3. Thereby it is possible to consider and calculate the
individual dependency concerning treatment plan, lat-
erality and analyzed structures. The model for assessing
the correlations between the different treatment tech-
niques was based on unstructured covariance patterns.
Concerning intraindividual factors of laterality and
structure, no correlations are expected in terms of mea-
sured BEDs, which are also considered in the calculated
model. In all analyses a p-value <0.05 was considered
as statistically significant. To account for multiplicity
we applied Bonferroni adjustment.dified according to [10].
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Demographic and tumor characteristics of 47 patients
studied are given in Table 1. The tumor was located for 18
patients in the left hemisphere, for 18 patients in the right
hemisphere and for 11 patients centrally. In these cases
the tumor was arbitrarily allocated to the left or right
hemisphere for analysis purposes according to its domin-
ating laterality. To fulfil the conventional constraints, 27
patients received 3 D conformal plans and 20 patients ini-
tially m3-IMSRT in their original treatment plans without
optimizing for hippocampi and SVZ. Dose constraints
were respected in all conventionally contoured organs at
risk in all plans. For optimized IMSRT-7 and IMSRT-14
plans the maximum doses for these OARs remained un-
changed, while an optimization was performed for sparing
of both hippocampi and SVZ. Topographic groups A, B,
C and D comprised in 11, 8, 14 and 14 patients respect-
ively (Table 1, Figure 2). None had multifocal tumor.
Normal brain exposure, conformity index, homogeneity
index and quality of coverage
The dose administered to 10%, 50% and 90% of the nor-
mal brain volume, outside the target volume (D 10, D 50,Table 2 Normal brain radiation exposure (median doses [Gy]










D 10 (Gy) b 25.290 26.240 24.450 0
Q25: 13.090 Q25:12.280 Q25: 12.400
Q75: 33.820 Q75: 34.740 Q75: 33.300
D 50 (Gy) b 7.000 6.510 6.500 0
Q25: 3.960 Q25: 3.550 Q25: 3.480
Q75: 10.900 Q75: 10.080 Q75: 10.100
D 90 (Gy) b 1.400 1.900 1.950 <
Q25: 1.100 Q25: 1.420 Q25: 1.460
Q75: 3.280 Q75: 3.300 Q75: 3.280
conformality
index c
0.980 0.990 1.000 0
Q25: 0.970 Q25: 0.990 Q25: 0.990
Q75: 1.000 Q75: 1.000 Q75: 1.000
homogeneity
index c
1.140 1.110 1.090 <
Q25: 1.100 Q25: 1.090 Q25: 1.070
Q75: 1.170 Q75: 1.120 Q75: 1.110
quality of
coverage c
0.920 0.930 0.920 0
Q25: 0.850 Q25: 0.890 Q25: 0.880
Q75: 0.950 Q75: 0.930 Q75: 0.940
Comparison between not optimized dose distribution and plans optimized for hipp
using 7 or 14 beamlets (IMSRT-7, IMSRT-14). p: p-value from non-parametric Wilcox
a : 27 plans: 3 D conformal, 20 plans: IMSRT optimized for conventionally contoured
b : D10, D50, D90: the median dose (Gy) + quartile to 10, 50 and 90% of the normal
c : conformity index: VRT/TV, homogeneity index: Imax/R, quality of coverage: Imin/and D 90) varies for each treatment modality and proofed
independent from the planning procedure (Table 2). How-
ever, when 90% of the normal brain volume is considered
optimized, planning with IMSRT-7 or IMSRT-14 results in
a small but significantly higher radiation exposure com-
pared to the not optimized plans. D 90 slightly further in-
creased using 14 beamlets compared to 7 (Table 2). Indeed
exposure of a larger normal tissue volume at low dose
levels is a hallmark of increasing number of beamlets in
IMSRT. Both CI and HI of planning treatment volume
show a small but significant improvement for the optimized
IMSRT-7 and to the IMSRT-14 plans compared to the not
optimized plans, albeit plans were not optimized for these
parameters. The quality of coverage of the IMSRT plans
compared to the not optimized plans remained unchanged
(Table 2). Overall hippocampus and SVZ sparing was not
achieved at the expense of quality of dose distribution at
the target volume.
Itemized observation of parameters (laterality, plan,
group, structure)
For the entire group (n = 47) dose reduction was achieved














ocampus and SVZ sparing by intensity modulated stereotactic radiotherapy
on-(rank sum)- test.
organs at risk.
brain volume (ml) left after the PTV volume was excluded.
RI.
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levels of sparing were favorable when the PTV was located
contralateral to hippocampus and SVZ (Figure 3 A-D).
In line with the linear mixed model significances regard-
ing variables structure to be spared (both hippocampi and
SVZ), the topographic site of PTV (group A-D), its lateral-
ity (ipsilataral or contralateral to the PTV) and the mode
of planning (not optimized, IMSRT-7, IMSRT-14) were
observable (p < 0.0001), which could not be interpreted in-
dependent due to interactions (Table 3). No significances
can be proved between laterality and structures as well as
between laterality or structures and different treatment
plans. In contrast laterality, structures and treatment plans
interact with group classification significantly (p < 0.0001/
p = 0.0013/p = 0.0062). Due to inconclusiveness no add-
itional higher-order interdependency could be established
(p > 0.1237). A significant difference exists for the laterality
concerning group A, B and C (p < 0.0001) and for the struc-
tures regarding to group A and B (p < 0.0001; p = 0.0028)
on a closer examination of group assignment. Referring to
treatment plans significant differences for group B, C and D
are verifiable (p < 0.0001), but even more precisely for
IMSRT 7 and IMSRT 14 in comparison with the not opti-




Figure 3 Mean biologic effective doses (BED Gy 2, linear quadratic m
subventricular zones ipsi- and contralateral for topographic groups A
IMRT-14 (definition see text).techniques no statistically significant difference is detected
in each group.
Group assignment has an effect on laterality, structures
and treatment plans, whereas the interaction between treat-
ment plans and laterality, respectively structure is not sig-
nificant. For group B, C and D is it possible to optimize the
treatment plan concerning organs at risk with IMSRT 7 as
well as IMSRT 14 compared to not optimized plans.
Comparison of 7 and 14 beamlets IMSRT concerning
OARs
A Bland-Altman plot displays the agreement between der
IMSRT-7 and IMRST-14 technique including the limits of
agreement for each organ at risk (Figures 4, 5, 6, 7). A slight
bias about the mean for ipsi- and contralateral hippocampus
and SZV with marginal numbers of outliers beyond limits of
agreement can be observed. The 14 beamlets IMSRT tech-
niques provides total doses to contralateral hippocampus
and SVZ, which ranges from 15% and 19% smaller, till 13%
and 25% higher than with the 7 beamlets technique, respect-
ively. The ipsilateral total doses for hippocampus and SVZ
ranges from 93% to 108% and 87% to 116% with IMSRT-14
compared to IMRST-7. The total doses for the ipsilateral
hippocampus is in 95% of all IMSRT-14 plans not more
than 8% higher or 7% lower compared to IMSRT-7 plans.odel, alpha-beta ratio: 2) at the hippocampus and the
-D depending on the planning mode not optimized, IMRT-7 or












* is an indication for multi structure analysis (2 together).
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IMSRT-14/IMSRT-7 ratio are within the range of 87% to
116%, i.e. it is expected that IMSRT-14 dose is not more
than 13% lower or 16% higher compared to the IMSRT-7
dose. Furthermore, a small bias is inherent, when doses at
contralateral hippocampus and SVZ are calculated using
IMSRT-14. Techniques can be used interchangeable.
Adding them to the inverse optimization target func-
tion of a dedicated IMSRT considerably reduces the dose
burdens at hippocampi and SVZ. Sparing at these struc-
tures critically depends on the relationship between the
site of the tumor and the organ to be spared and its lat-
erality. It seems reasonable to assume, that localization
of tumor related to SVZ and hippocampus has an im-
portant impact on choice of treatment technique.Figure 4 Mean and standard deviation of differences between total d
with IMSRT-14 vs. IMSRT-7 in 46 patients (Bland-Altman plot); limits oDiscussion
Neurotoxicity after radiotherapy has been classified as acute,
subacute and late. Beside a variety of morphological changes
detected in MRT (e.g. white matter lesions) and histologi-
cally, neurocognitive changes observed particularly in long
term survivors have been associated with brain irradiation
[6]. It is assumed, that the clinical counterpart of diffuse
white matter changes may be a declined neurocognitive
function, observed in children after fractionated total doses
as low as 18 Gy to 24 Gy in 2 Gy fractions (BED = 36…
48 Gy2 using α/β ratio of 2) [13]. This issue is of growing
importance since survival has risen gradually over the past
decade in virtually all malignant brain tumors. Recent re-
ports on anaplastic glioma and GBM demonstrated an in-
creased survival approaching a median of two years after
escalated doses, e.g. applied by a stereotactic boost or by
re-irradiation after recurrence, but also adverse long term
neurotoxicity [14-17]. However, with more sensitive testing
tools, neurocognitive decline can be detected as early as
4 months. After whole brain irradiation for brain metasta-
ses with 30 Gy, 52% of patients show a decline in learning
and memory function compared to 24% in patients treated
with stereotactic irradiation for 1–3 brain metastases alone
[18]. Toxicity data from low-grade glioma patients treated
with radiation doses of 50 Gy reported an actuarial 5-year
incidence of mental decline of 5.3% [19]. Neurocognitive
changes may be detected after a long clinically silent
period up to 12 years after radiotherapy for anaplastic
oligodendroglioma brain tumours [20], albeit cognitive
dysfunction may be present before treatment begun [21].
Several factors are known to impact the development ofoses at the hippocampus ipsilateral to the PTV when irradiated
f agreement (mean+/-1.96*SD) in original scale: +8%/-7%.
Figure 5 Mean and standard deviation of differences between total doses at the hippocampus contralateral to the PTV when
irradiated with IMSRT-14 vs. IMSRT-7 in 47 patients (Bland-Altman plot); limits of agreement (mean+/-1.96*SD) in original
scale: +13%/-15%.
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tween radiation dose and risk or severity of findings has
not been established.
Extensive experimental research during the last 15 years
has begun to elucidate the pathophysiologic mechanisms
that may underlie neurocognitive dysfunction after radio-
therapy of the brain. Radiotherapy and chemotherapyFigure 6 Mean and standard deviation of differences between total d
irradiated with IMSRT-14 vs. IMSRT-7 in 47 patients (Bland-Altman plo
scale: +16%/-13%.impact on normal (adult) neurogenesis originating in
brain stem cells localized in dentate gyrus of the hippo-
campus and the subventricular zones around the lateral
ventricles [6,22,23].
Hippocampal neurogenesis is a very complex physio-
logical process [1]. Neuronal stem cells localized in the
subventricular zone are considered to maintain whiteoses at the subventricular zone ipsilateral to the PTV when
t); limits of agreement (mean+/-1.96*SD) in original
Figure 7 Mean and standard deviation of differences between total doses at the subventricular zone contralateral to the PTV when
irradiated with IMSRT-14 vs. IMSRT-7 in 47 patients (Bland-Altman plot); limits of agreement (mean+/-1.96*SD) in original
scale: +25%/-19%.
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gyrus of the hippocampus occurs in both rats and humans
throughout life, and the addition of these new neurons is
believed to be important to normal memory function
[24-26]. Experimental and human studies have docu-
mented that radiation is able to disrupt the neurogenesis
in the adult dentate gyrus even after exposure to single
doses as low as 6 Gy, which is equivalent to 12 Gy given
in 6 fractions with 2 Gy each (both resulting in BED of
24 Gy2 assuming a α/β ratio of 2) [4,23,27-30]. This may
contribute to the clinical finding of neurocognitive decline
after radiotherapy performed with low doses for brain me-
tastases. Due to the proximity of the target volumes and
their exposition with high doses while simultaneous spar-
ing of hippocampal structures, the constraints for the lat-
ter may only be accomplished in a subgroup of tumor
and / or using sophisticated and dedicated radiotherapy
planning procedures. The present series demonstrate bet-
ter sparing of contralateral neural stem cell niches com-
pared to ipsilateral. The topographic site of PTV seems to
impact the degree of sparing capability. In the present
series, total doses at the neural stem cell niches are below
doses associated with neurogenic impairment (after whole
brain irradiation in children and adults) and even the dose
range leading to a disruption of the neurogenesis in mouse
models particularly in patients of group D (tumor involv-
ing neither subventricular zone nor cortex). Patients with
such tumors may benefit most from dedicated IMSRT
planning.
In conventional radiotherapy planning however nei-
ther the hippocampus nor the SVZ are contoured and
considered as organs at risk during the topographicaldose optimization process. Better sparing of normal brain
tissue has been accomplished with IMSRT substituting 3D
conformal dose escalated radiotherapy for high grade gli-
oma with a consecutively reduced normal tissue complica-
tion probability in a radiobiological modelling study [31].
In patients requiring whole brain irradiation due to brain
metastases, IMSRT has been shown to better spare the
hippocampus both by linac based technique as well as by
tomotherapy, when these organs at risk have been subjected
to a high penalty in the inverse optimization algorithm
[14,32,33].
IMSRT-7 and IMSRT-14 was optimized for sparing of
the hippocampi and the SVZ. The dose homogeneity at the
PTV as well as conformity index improved as an unsched-
uled side effect. The data presented demonstrate a consid-
erable sparing achieved by contouring neuronal stem cell
niches and exploiting the capabilities of micromultileaf col-
limation and dedicated dose optimization in a stereotactic
treatment setting. The extent of sparing depends on the size
of PTV but also its topographic site described by its relation
to the cortex and the lateral ventricles. Additional model-
ling of high isodoses had only a marginal impact on sparing.
This may be a valuable finding because it has the potential
to prevent physicists from additional planning burden.
The Bland-Altman plot is a graphical method to show
the relation between the differences and averages of two
techniques, to control for systematic bias and to identify
outliers. For clinically evaluation and interpretation of the
data a back-transform of logarithm is practicable. The clin-
ical importance of advancement between the two tech-
niques can be measured against each other on the basis of
percentages in original scale. The Bland-Altman plot also
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with 7 and 14 beamlets. Thereby no advantages with 14
beamlets over 7 beamlets are detectable.
The analysis seems reasonable to assume that localization
of tumor related to SVZ and hippocampus has an import-
ant impact on choice of treatment technique. It is possible
to optimize the treatment plan concerning organs at risk
with IMSRT-7 as well as IMSRT-14 compared to non opti-
mized plans for group B, C and D. On the contrary the dif-
ferent treatment techniques have no preserving effect for
organs at risk when the tumor contacts SVZ and cortex ir-
respective of laterality.
The patient bases of this study were cases already treated
with 3D-conformal SRT. The optimal beam directions for
the 3D-SRT plans avoid direct interaction with any OAR
and were already optimized by experienced medical physi-
cists. The beam directions have been left unchanged be-
cause they allowed best sparing and were the ideal solution
for every case. It is in our opinion highly recommended to
use non-coplanar beam setups for cranial indications due
to increase the number of degrees of freedom.
The aim of modern planning is not only to reduce the
doses at the remaining normal brain and standard OAR,
which has been correlated with different treatment methods
[34], but also to spare sites where neurogenesis takes place,
more specifically. However, an unsolved issue is the dose to
be targeted at the hippocampus and the SVZ particularly
according to the obviously multifactorial impairment of
stem cell regeneration, in which corticoids and anticonvul-
sive drugs interfere with radiation [5]. In this series a total
dose of 6 Gy over the entire series of fractionated radiother-
apy was used as dose constraint. Others set the dose to
zero, which seems unrealistic [8]. Recently a dose of 7 Gy at
the hippocampus has been shown to impair late memory
[35]. This figure could arbitrarily serve as a constraint in
IMSRT however needs further confirmation.
Competing interests
Thomas G. Wendt, Tilo Wiezorek and Nico Banz received honorarium from
Brainlab AG independent from this work. All other authors declare that they
have no competing interests.
Authors’ contributions
JO carried out the contouring of critical structures, data management,
performed the data analysis and statistics, reviewed the literature and
contributed to writing the manuscript. TB prepared data set for contouring
and generating experimental data. TGW was responsible for the study
design, coordination, treatment planning and contributed to the final draft.
MW advised statistical procedures, recalculated results and contributed to
the draft. NB carried out MRI fusions and participated in the statistical
analysis of the results and helped revising the draft. TW carried out the
treatment planning and helped revising the draft. All authors read and
approved the final manuscript.
Author details
1Department of Radiation Oncology, Jena University Hospital,
Friedrich-Schiller-University Jena, Bachstrasse 18, Jena D-07743, Germany.
2Department of Radiation Oncology, Division of Medical Physics, Jena
University Hospital, Friedrich-Schiller-University Jena, Bachstrasse 18, Jena
D-07743, Germany. 3Institute of Medical Statistics, Computer Sciences andDocumentation, Jena University Hospital, Friedrich-Schiller-University Jena,
Bachstrasse 18, Jena D-07743, Germany.
Received: 1 April 2013 Accepted: 21 July 2013
Published: 24 July 2013
References
1. Kempermann G: The neurogenic reserve hypothesis: what is adult
hippocampal neurogenesis good for? Trends Neurosci 2008, 31:163–169.
2. Doetsch F, Caillé I, Lim DA, García-Verdugo JM, Alvarez-Buylla A:
Subventricular zone astrocytes are neural stem cells in the adult
mammalian brain. Cell 1999, 97:703–716.
3. Gage FH: Mammalian neural stem cells. Science 2000, 287(5457):1433–1438.
4. Mizumatsu S, Monje ML, Morhardt DR, Rola R, Palmer TD, Fike JR: Extreme
sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res
2003, 63:4021–4027.
5. Correa DD: Neurocognitive Function in Brain Tumors. Current Neurol
Neuroscience Rep 2010, 10:232–239.
6. Dietrich J, Monje M, Wefel J, Meyers C: Clinical patterns and biological
correlates of cognitive dysfunction associated with cancer therapy.
Oncologist 2008, 13:1285–1295.
7. Chera BS, Amdur RJ, Patel P, Mendenhall WM: A Radiation Oncologist's
Guide to Contouring the Hippocampus. Am J Clin Oncol-Cancer Clinical
Trials 2009, 32:20–22.
8. Barani IJ, Cuttino LW, Benedict SH, Todor D, Bump E, Wu Y, Chung T,
Broaddus W, Lin P: Neural stem cell-preserving external beam
radiotherapy of central nervous system malignancies. Int J Radiat Oncol
Biol Phys 2007, 68:978–985.
9. Feuvret L, NoËl G, Mazeron J-J, Bey P: Conformity Index: A review. Int J Radiat
Oncol Biol Phys 2006, 64:333–342.
10. Kappadakunnel M, Eskin A, Dong J, Nelson SF, Mischel PS, Liau LM,
Ngheimphu P, Lai A, Cloughesy TF, Goldin J, Pope WB: Stem cell
associated gene expression in glioblastoma multiforme: relationship to
survival and the subventricular zone. J Neurooncol 2010, 96:359–367.
11. Lim DA, Cha S, Mayo MC, Chen MH, Keles E, Vandenberg S, Berger MS:
Relationship of glioblastoma multiforme to neural stem cell regions predicts
invasive and multifocal tumor phenotype. Neuro Oncol 2007, 9:424–428.
12. Bland JM, Altman DG: Statistical methods for assessing agreement between
two methods of clinical measurement. Lancet 1986, 8476:307–310.
13. Kortmann RD, Timmermann B, Taylor RE, Scarzello G, Plasswilm L, Paulsen F,
Jeremic B, Gnekow AK, Dieckmann K, Kay S, Bamberg M: Current and
Future Strategies in Radiotherapy of Childhood Low-Grade Glioma of
the Brain. Part II: Treatment-Related Late Toxicity. Strahlenther Onkol 2003,
179:585–597.
14. Balducci M, Apicella G, Manfrida S, Mangiola A, Fiorentino A, Azario L,
D'Agostino GR, Frascino V, Dinapoli N, Mantini G, Albanese A, De Bonis P,
Chiesa S, Valentini V, Anile C, Cellini N: Single-arm phase II study of
conformal radiation therapy and temozolomide plus fractionated
stereotactic conformal boost in high-grade gliomas: final report.
Strahlenther Onkol 2010, 186:558–564.
15. Baumert BG, Lutterbach J, Bernays R, Davis JB, Heppner FL: Fractionated
stereotactic radiotherapy boost after post-operative radiotherapy in
patients with high-grade gliomas. Radiother Oncol 2003, 67:183–190.
16. Fokas E, Wacker U, Gross MW, Henzel M, Encheva E, Engenhart-Cabillic R,
185: Hypofractionated stereotactic reirradiation of recurrent
glioblastomas. A beneficial treatment option after high-dose
radiotherapy? Strahlenther Onkol 2009, 185:235–240.
17. Henke G, Paulsen F, Steinbach JP, Ganswindt U, Isijanov H, Kortmann RD,
Bamberg M, Belka C: Hypofractionated reirradiation for recurrent
malignant glioma. Strahlenther Onkol 2009, 185:113–119.
18. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint
JM, Shiu AS, Maor MH, Meyers CA: Neurorecognition in patients with brain
metastases treated with radiosurgery or radiosurgery plus wholebrain
irradiation: a randomised controlled trial. Lancet Oncol 2009, 10:1037–1044.
19. Laack NN, Brown PD, Ivnik RJ, Furth AF, Ballman KV, Hammack JE, Arusell
RM, Shaw EG, Buckner JC: Cognitive function after radiotherapy for
supratentorial low grade glioma: a North Central Cancer Treatment
Group prospective study. Int J Radiat Oncol Biol Phys 2005, 63:1175–1183.
20. Van den Bent MJ, Brandes AA, Taphoorn MJ, Kros JM, Kouwenhoven MC,
Delattre JY, Bernsen HJ, Frenay M, Tijssen CC, Grisold W, Sipos L, Enting RH,
French PJ, Dinjens WN, Vecht CJ, Allgeier A, Lacombe D, Gorlia T, Hoang-
Oehler et al. Radiation Oncology 2013, 8:187 Page 11 of 11
http://www.ro-journal.com/content/8/1/187Xuan K: Adjuvant procarbazine, lomustine, and vincristine chemotherapy
in newly diagnosed anaplastic oligodendroglioma: long-term follow-up
of EORTC brain tumor group study 26951. J Clin Oncol 2013, 31:344–350.
21. Welzel G, Fleckenstein K, Mai SK, Hermann B, Kraus-Tiefenbacher U, Wenz F:
Acute Neurocognitive Impairment during Cranial Radiation Therapy in
Patients with Intracranial Tumors. Strahlenther Onkol 2008, 184:647–654.
22. Abayomi OK: Pathogenesis of Cognitive Decline Following Therapeutic
Irradiation for Head and Neck Tumors. Acta Oncol 2002, 41:346–351.
23. Monje ML, Vogel H, Masek M, Ligon KL, Fisher PG, Palmer TD: Impaired
human hippocampal neurogenesis after treatment for central nervous
system malignancies. Ann Neurol 2007, 62:515–520.
24. Kempermann G: Seven principles in the regulation of adult neurogenesis.
Eur J Neurosci 2011, 33:1018–1024.
25. Shors TJ, Townsend DA, Zhao M, Kozorovitskiy Y, Gould E: Neurogenesis
may relate to some but not all types of hippocampal-dependent
learning. Hippocampus 2002, 12:578–584.
26. Saxe MD, Battaglia F, Wang JW, Malleret G, David DJ, Monckton JE, Garcia
AD, Sofroniew MV, Kandel ER, Santarelli L, Hen R, Drew MR: Ablation of
hippocampal neurogenesis impairs contextual fear conditioning and
synaptic plasticity in the dentate gyrus. Proc Natl Acad Sci U S A 2006,
103:17501–17506.
27. Fike JR, Rosi S, Limoli CL: Neural Precursor Cells and CNS Radiation
Sensitivity. Semin Radiat Oncol 2009, 19:22–32.
28. Lazarini F, Mouthon M-A, Gheusi G, De Chaumont F, Olivo-Marin J-C,
Lamarque S, Abrous DN, Boussin FD, Lledo PM: Cellular and Behavioral
Effects of Cranial Irradiation of the Subventricular Zone in Adult Mice.
PLoS One 2009, 4:e7017.
29. Peißner W, Kocher M, Treuer H, Gillardon F: Ionizing radiation-induced
apoptosis of proliferating stem cells in the dentate gyrus of the adult rat
hippocampus. Molecul Brain Res 1999, 71:61–68.
30. Rola R, Fishman K, Baure J, Rosi S, Lamborn KR, Obenaus A, Nelson GA, Fike
JR: Hippocampal Neurogenesis and Neuroinflammation after Cranial
Irradiation with 56Fe Particles. Radiat Res 2008, 169:626–632.
31. De La Fuente Herman T, Ahmada S, Vlachaki MT: Intensity modulated
radiation therapy versus three dimensional conformal radiation therapy
for treatment of high grade glioma: A radiobiological modeling study.
J X-ray Science Technol 2010, 18:393–402.
32. Gondi V, Tolakanahalli R, Mehta MP, Tewatia D, Rowley H, Kuo JS, Khuntia D,
Tomé WA: Hippocampal-Sparing Whole-Brain Radiotherapy: A “How-To”
Technique Using Helical Tomotherapy and Linear Accelerator–Based
Intensity-Modulated Radiotherapy. Int J Radiat Oncol Biol Phys 2010,
78:1244–1252.
33. Marsh JC, Gielda BT, Herskovic AM, Wendt JA, Turian JV: Sparing of the
hippocampus and limbic circuit during whole brain radiation therapy:
A dosimetric study using helical tomotherapy. J Med Imag Radiat Oncol
2010, 54:375–382.
34. Zach L, Stall B, Ning H, Ondos J, Arora B, Uma S, Miller RW, Citrin D,
Camphausen K: A dosimetric comparison of four treatment planning
methods for high grade glioma. Radiat Oncol 2009, 4:45.
35. Gondi V, Hermann BP, Mehta MP, Tomé WA: Hippocampal Dosimetry
Predicts Neurocognitive Function Impairment After Fractionated
Stereotactic Radiotherapy for Benign or Low-Grade Adult Brain Tumors.
Int J Radiation Oncol Biol Phys 2013, 85(2):348e–354e.
doi:10.1186/1748-717X-8-187
Cite this article as: Oehler et al.: Neural stem cell sparing by linac based
intensity modulated stereotactic radiotherapy in intracranial tumors.
Radiation Oncology 2013 8:187.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
